Various concentrations (0. 1 – 100 μM) of compounds were plated in white 384-well plates (Greiner) and were incubated with 10 nM biotinylated Aβ42 (Anaspec) and 1 nM fibrinogen for 30 min at room temperature (RT) in a final volume of 10 μl assay buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween-20, and 0.1% BSA). The mixture was then incubated with anti-fibrinogen antibody (Dako), 20 μg/ml streptavidin-conjugated donor, and protein A-conjugated acceptor beads (PerkinElmer) for 90 min at RT. Samples were read by a PerkinElmer EnVision plate reader. RU-505, which is a known inhibitor of Aβ42-fibrinogen interaction27 (link), was used as a positive control and also for comparison of its efficacy with other compounds. All the experiments were performed in triplicate. To determine IC50 of compounds, the data were fitted to a sigmoidal dose-response equation (Y= Bottom + (Top − Bottom)/1 + 10(logIC50 − x) Hill coefficient)) using GraphPad Prism 4 to calculate IC50.